Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Amgen Inc. Drug Patent Portfolio

Amgen Inc. owns 2 purple book drugs protected by 48 US patents Given below is the list of Amgen Inc.'s drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11744950 Controlled dispense syringe 21 Nov, 2039
Active
US11098079 Charged depth filtration of antigen-binding proteins 21 Jul, 2037
Active
US11275090 Quantitation of glycan moiety in recombinant glycoproteins 02 Jul, 2037
Active
US10167492 Process for manipulating the level of glycan content of a glycoprotein 01 Dec, 2035
Active
US10822630 Process for manipulating the level of glycan content of a glycoprotein 01 Dec, 2035
Active
US11786866 Process control systems and methods for use with filters and filtration processes 21 Oct, 2035
Active
US10583397 Process control systems and methods for use with filters and filtration processes 28 Jul, 2035
Active
US11384378 Methods for harvesting mammalian cell cultures 04 Jun, 2035
Active
US11427848 Methods for harvesting mammalian cell cultures 04 Jun, 2035
Active
US11077404 Process control systems and methods for use with filters and filtration processes 13 May, 2035
Active
US11130980 Use of monensin to regulate glycosylation of recombinant proteins 05 Apr, 2035
Active
US10106829 Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
Active
US10227627 Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
Active
US10655156 Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
Active
US10907186 Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
Active
US10513723 Decreasing ornithine production to decrease high mannose glycoform content of recombinant proteins 09 Dec, 2034
Active
US11254963 Increasing ornithine accumulation to increase high mannose glycoform content of recombinant proteins 09 Dec, 2034
Active
US11299760 Use of monensin to regulate glycosylation of recombinant proteins 30 Oct, 2034
Active
US10421987 Methods for increasing mannose content of recombinant proteins 29 May, 2034
Active
US10894972 Methods for increasing mannose content of recombinant proteins 29 May, 2034
Active
US11434514 Methods for increasing mannose content of recombinant proteins 29 May, 2034
Active
US11946085 Methods for increasing mannose content of recombinant proteins 29 May, 2034
Active
US9481901 Methods for increasing mannose content of recombinant proteins 29 May, 2034
Active
US11319568 Methods for increasing mannose content of recombinant proteins 10 Mar, 2034
Active
US11459595 Methods for increasing mannose content of recombinant proteins 10 Mar, 2034
Active
US11952605 Methods for increasing mannose content of recombinant proteins 10 Mar, 2034
Active
US9328134 Carbohydrate phosphonate derivatives as modulators of glycosylation 20 Feb, 2034
Active
US11486883 Method for using light scattering in real time to directly monitor and control impurity removal in purification processes 26 Mar, 2033
Active
US11292829 Mammalian cell culture 29 Jun, 2032
Active
US11634476 Mammalian cell culture 29 Jun, 2032
Active
US11685772 Mammalian cell culture 29 Jun, 2032
Active
US9133493 Method for culturing mammalian cells to improve recombinant protein production 20 Apr, 2032
Active
US9388447 Method for culturing mammalian cells to improve recombinant protein production 20 Apr, 2032
Active
US9012178 Dipeptides to enhance yield and viability from cell cultures 05 Aug, 2031
Active
US9320816 Methods of treating cell culture media for use in a bioreactor 14 Nov, 2030
Active
US9856287 Refolding proteins using a chemically controlled redox state 21 Jun, 2030
Active
US8053236 Feed media 19 Jan, 2030
Active
US9228168 Feed media 19 Jan, 2030
Active
US9359435 Methods for modulating mannose content of recombinant proteins 22 May, 2027
Active
US7662930 Polishing steps used in multi-step protein purification processes 24 Apr, 2027
Active
US7888101 Host cells comprising alpha 1,2 mannosidase and culture methods thereof 06 Apr, 2027
Active
US7928205 Methods for refolding of recombinant antibodies 12 Feb, 2027
Active
US8247210 Host cells comprising alpha 1,2 mannosidase and culture methods thereof 06 Dec, 2026
Active
US8460896 Host cells and culture methods 06 Dec, 2026
Active
US8680248 Host cells comprising alpha 1,2 mannosidase and culture methods thereof 06 Dec, 2026
Active
US7427659 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction 15 Mar, 2025
Active
US7364736 Antibodies to OPGL 19 Feb, 2025
Active
US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL 30 Nov, 2023
Active


Amgen Inc.'s Family Patents


Family Patents



Amgen Inc. Drug List

Given below is the complete list of Amgen Inc.'s drugs and the patents protecting them.


1. Neulasta

Neulasta is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9856287 Refolding proteins using a chemically controlled redox state 21 Jun, 2030
(5 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Neulasta's drug page


2. Prolia And Xgeva

Prolia And Xgeva is protected by 47 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11744950 Controlled dispense syringe 21 Nov, 2039
(14 years from now)
Active
US11098079 Charged depth filtration of antigen-binding proteins 21 Jul, 2037
(12 years from now)
Active
US11275090 Quantitation of glycan moiety in recombinant glycoproteins 02 Jul, 2037
(12 years from now)
Active
US10167492 Process for manipulating the level of glycan content of a glycoprotein 01 Dec, 2035
(10 years from now)
Active
US10822630 Process for manipulating the level of glycan content of a glycoprotein 01 Dec, 2035
(10 years from now)
Active
US11786866 Process control systems and methods for use with filters and filtration processes 21 Oct, 2035
(10 years from now)
Active
US10583397 Process control systems and methods for use with filters and filtration processes 28 Jul, 2035
(10 years from now)
Active
US11384378 Methods for harvesting mammalian cell cultures 04 Jun, 2035
(10 years from now)
Active
US11427848 Methods for harvesting mammalian cell cultures 04 Jun, 2035
(10 years from now)
Active
US11077404 Process control systems and methods for use with filters and filtration processes 13 May, 2035
(10 years from now)
Active
US11130980 Use of monensin to regulate glycosylation of recombinant proteins 05 Apr, 2035
(10 years from now)
Active
US10106829 Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
(9 years from now)
Active
US10227627 Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
(9 years from now)
Active
US10655156 Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
(9 years from now)
Active
US10907186 Overexpression of n-glycosylation pathway regulators to modulate glycosylation of recombinant proteins 11 Dec, 2034
(9 years from now)
Active
US10513723 Decreasing ornithine production to decrease high mannose glycoform content of recombinant proteins 09 Dec, 2034
(9 years from now)
Active
US11254963 Increasing ornithine accumulation to increase high mannose glycoform content of recombinant proteins 09 Dec, 2034
(9 years from now)
Active
US11299760 Use of monensin to regulate glycosylation of recombinant proteins 30 Oct, 2034
(9 years from now)
Active
US10421987 Methods for increasing mannose content of recombinant proteins 29 May, 2034
(9 years from now)
Active
US10894972 Methods for increasing mannose content of recombinant proteins 29 May, 2034
(9 years from now)
Active
US11434514 Methods for increasing mannose content of recombinant proteins 29 May, 2034
(9 years from now)
Active
US11946085 Methods for increasing mannose content of recombinant proteins 29 May, 2034
(9 years from now)
Active
US9481901 Methods for increasing mannose content of recombinant proteins 29 May, 2034
(9 years from now)
Active
US11319568 Methods for increasing mannose content of recombinant proteins 10 Mar, 2034
(9 years from now)
Active
US11459595 Methods for increasing mannose content of recombinant proteins 10 Mar, 2034
(9 years from now)
Active
US11952605 Methods for increasing mannose content of recombinant proteins 10 Mar, 2034
(9 years from now)
Active
US9328134 Carbohydrate phosphonate derivatives as modulators of glycosylation 20 Feb, 2034
(9 years from now)
Active
US11486883 Method for using light scattering in real time to directly monitor and control impurity removal in purification processes 26 Mar, 2033
(8 years from now)
Active
US11292829 Mammalian cell culture 29 Jun, 2032
(7 years from now)
Active
US11634476 Mammalian cell culture 29 Jun, 2032
(7 years from now)
Active
US11685772 Mammalian cell culture 29 Jun, 2032
(7 years from now)
Active
US9133493 Method for culturing mammalian cells to improve recombinant protein production 20 Apr, 2032
(7 years from now)
Active
US9388447 Method for culturing mammalian cells to improve recombinant protein production 20 Apr, 2032
(7 years from now)
Active
US9012178 Dipeptides to enhance yield and viability from cell cultures 05 Aug, 2031
(6 years from now)
Active
US9320816 Methods of treating cell culture media for use in a bioreactor 14 Nov, 2030
(5 years from now)
Active
US8053236 Feed media 19 Jan, 2030
(5 years from now)
Active
US9228168 Feed media 19 Jan, 2030
(5 years from now)
Active
US9359435 Methods for modulating mannose content of recombinant proteins 22 May, 2027
(2 years from now)
Active
US7662930 Polishing steps used in multi-step protein purification processes 24 Apr, 2027
(2 years from now)
Active
US7888101 Host cells comprising alpha 1,2 mannosidase and culture methods thereof 06 Apr, 2027
(2 years from now)
Active
US7928205 Methods for refolding of recombinant antibodies 12 Feb, 2027
(2 years from now)
Active
US8247210 Host cells comprising alpha 1,2 mannosidase and culture methods thereof 06 Dec, 2026
(1 year, 11 months from now)
Active
US8460896 Host cells and culture methods 06 Dec, 2026
(1 year, 11 months from now)
Active
US8680248 Host cells comprising alpha 1,2 mannosidase and culture methods thereof 06 Dec, 2026
(1 year, 11 months from now)
Active
US7427659 Process for purifying proteins in a hydrophobic interaction chromatography flow-through fraction 15 Mar, 2025
(2 months from now)
Active
US7364736 Antibodies to OPGL 19 Feb, 2025
(2 months from now)
Active
US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL 30 Nov, 2023
(1 year, 19 days ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Prolia And Xgeva's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List